AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aquestive Therapeutics, Inc. Director's Dealing 2019

Aug 20, 2019

Director's Dealing

Opens in your device viewer

Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2019-08-09

Reporting Person: Kendall Keith J (N/A)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-09	Common Stock	P	2000	$3.84	Acquired	648581	Direct
2019-08-09	Common Stock	P	1000	$3.925	Acquired	649581	Direct
2019-08-09	Common Stock	P	2000	$3.995	Acquired	651581	Direct
2019-08-13	Common Stock	P	1000	$4.045	Acquired	652581	Direct
2019-08-14	Common Stock	P	1000	$3.697	Acquired	653581	Direct
2019-08-14	Common Stock	P	1000	$3.65	Acquired	654581	Direct